Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTyratech Com Shares Regulatory News (TYRU)

  • There is currently no data for TYRU

Blocklisting Interim Review

18 Dec 2013 07:00

RNS Number : 7777V
TyraTech, Inc.
18 December 2013
 

 

18 December 2013

 

TYRATECH, INC.

("TyraTech" or the "Company")

 

Blocklisting Interim Review

 

TyraTech, Inc. (AIM: TYR and TYRU), a life sciences company focusing on natural insect and parasite control products, provides the following information in connection with its block admission pursuant to AIM Rule 29 and Schedule Six of the AIM Rules:

 

 

Name of company:

TyraTech, Inc.

 

Name of scheme:

2007 Equity Compensation Plan of the Company

 

Period of return:

From: 18 June 2013 To: 17 December 2013

 

Number and class of securities not issued under the scheme

5,164,996 common shares

 

 

Number of securities issued under the scheme during the period

Nil

 

 

Balance under the scheme of securities not yet issued at the end of the period

5,164,996 common shares

 

 

Number and class of securities originally admitted and the date of admission

5,183,746 common shares on 2 March 2011

 

 

Name of contact:

Daniel Williams

 

Telephone number of contact:

+1 919 415 4285

 

 

 

 

For further information please contact:

 

TyraTech Inc.Alan Reade, Non-Executive ChairmanTel: +44 7841 978 709

 

Bruno Jactel, Chief Executive Officer

Tel: +1 919 415 4340

 

N+1 Singer, Nominated Adviser and Joint BrokerJonny Franklin-Adams / Alex WrightTel: +44 20 7496 3000

 

First Columbus LLP, Joint BrokerChris CrawfordTel: +44 20 3002 2070

 

Walbrook, Financial PR and IR

Bob Huxford /Guy McDougall (Public Relations)

Tel + 44 7933 8792

 

Paul Cornelius (Investor Relations)

Tel +44 20 7933 8794

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BLRUBAVROOAUAAA
Date   Source Headline
31st Jan 20144:26 pmRNSProposed Placing
23rd Jan 20145:58 pmRNSHolding(s) in Company
20th Jan 20147:00 amRNSHead-Lice Preventative Shampoo Coming to US Market
14th Jan 20147:00 amRNSChange of Adviser
14th Jan 20147:00 amRNSVamousse coming to Walmart stores in the USA
18th Dec 20137:00 amRNSBlocklisting Interim Review
25th Oct 20132:39 pmRNSDirector/PDMR Shareholding
7th Oct 20138:39 amRNSDirector/PDMR Shareholding
30th Sep 20137:00 amRNSInterim Results
14th Aug 20137:00 amRNSGlobal distribution agreement for biocide products
25th Jul 20136:11 pmRNSResult of AGM
27th Jun 20137:00 amRNSFinal Results
24th Jun 20137:00 amRNSDirectorate Changes
19th Jun 20139:59 amRNSBlocklisting Interim Review
11th Jun 20134:23 pmRNSDirectorate Change
31st May 201312:43 pmRNSMigration of Shares
11th Apr 20137:00 amRNSFrench Registration of Insect Repellent Product
9th Apr 20137:00 amRNSHolding(s) in Company
28th Mar 20136:09 pmRNSResult of Special Meeting
28th Mar 20134:15 pmRNSShare Migration
18th Mar 20137:00 amRNSProposed placing and subscription of common shares
4th Mar 20137:00 amRNSUK registration of insect repellent product
4th Feb 20137:00 amRNSFirst Patent Granted for ExtendT Technology
10th Jan 20137:00 amRNSDirectorate Change
7th Jan 201310:40 amRNSNew Anti-Endoparasitic Composition Patents
20th Dec 20127:00 amRNSIssue of Equity
18th Dec 20122:56 pmRNSBlocklisting Interim Review
18th Dec 20127:00 amRNSGerman Registration of Insect Repellent Product
17th Dec 20127:00 amRNSFirst Shipment of Retail Products
11th Dec 20127:00 amRNSHead Lice Product Registration in UK
4th Dec 20127:00 amRNSFormation of New Joint Venture
13th Nov 20127:00 amRNSU.S. Registration of New Insect Repellent Product
30th Oct 20127:00 amRNSAdvance Payment on Prospective New Alliance
29th Oct 20127:00 amRNSChange of Name of Adviser
16th Oct 201211:40 amRNSTyraTech Secures New Patent
16th Oct 20129:26 amRNSMigration of Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.